Structure

Physi-Chem Properties

Molecular Weight:  600.13
Volume:  576.625
LogP:  4.904
LogD:  1.694
LogS:  -4.651
# Rotatable Bonds:  5
TPSA:  219.1
# H-Bond Aceptor:  12
# H-Bond Donor:  7
# Rings:  6
# Heavy Atoms:  12

MedChem Properties

QED Drug-Likeness Score:  0.139
Synthetic Accessibility Score:  4.13
Fsp3:  0.156
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  1
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.867
MDCK Permeability:  4.562537014862755e-06
Pgp-inhibitor:  0.04
Pgp-substrate:  0.938
Human Intestinal Absorption (HIA):  0.983
20% Bioavailability (F20%):  0.565
30% Bioavailability (F30%):  1.0

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.0
Plasma Protein Binding (PPB):  84.00262451171875%
Volume Distribution (VD):  0.532
Pgp-substrate:  35.88127136230469%

ADMET: Metabolism

CYP1A2-inhibitor:  0.537
CYP1A2-substrate:  0.468
CYP2C19-inhibitor:  0.029
CYP2C19-substrate:  0.046
CYP2C9-inhibitor:  0.79
CYP2C9-substrate:  0.79
CYP2D6-inhibitor:  0.007
CYP2D6-substrate:  0.185
CYP3A4-inhibitor:  0.043
CYP3A4-substrate:  0.062

ADMET: Excretion

Clearance (CL):  1.777
Half-life (T1/2):  0.362

ADMET: Toxicity

hERG Blockers:  0.026
Human Hepatotoxicity (H-HT):  0.226
Drug-inuced Liver Injury (DILI):  0.982
AMES Toxicity:  0.169
Rat Oral Acute Toxicity:  0.008
Maximum Recommended Daily Dose:  0.945
Skin Sensitization:  0.821
Carcinogencity:  0.01
Eye Corrosion:  0.003
Eye Irritation:  0.811
Respiratory Toxicity:  0.02

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC469664

Natural Product ID:  NPC469664
Common Name*:   Hypochromin A
IUPAC Name:   5,6,8-trihydroxy-2-(2-hydroxypropyl)-9-[5,6,8-trihydroxy-4-oxo-2-(2-oxopropyl)benzo[g]chromen-9-yl]benzo[g]chromen-4-one
Synonyms:  
Standard InCHIKey:  DELYIJJKVUTVRM-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C32H24O12/c1-11(33)3-13-5-17(35)29-23(43-13)7-15-25(19(37)9-21(39)27(15)31(29)41)26-16-8-24-30(18(36)6-14(44-24)4-12(2)34)32(42)28(16)22(40)10-20(26)38/h5-11,33,37-42H,3-4H2,1-2H3
SMILES:  CC(Cc1cc(=O)c2c(o1)cc1c(c2O)c(O)cc(c1c1c(O)cc(c2c1cc1oc(CC(=O)C)cc(=O)c1c2O)O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1097203
PubChem CID:   46210036
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0001640] Naphthopyrans
        • [CHEMONTID:0001641] Naphthopyranones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO32888 hypocrea vinosa Species Hypocreaceae Eukaryota n.a. n.a. n.a. PMID[20192239]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT737 Cell Line HUVEC Homo sapiens IC50 = 50000.0 nM PMID[511216]
NPT737 Cell Line HUVEC Homo sapiens IC50 = 870.0 nM PMID[511216]
NPT737 Cell Line HUVEC Homo sapiens Inhibition = 100.0 % PMID[511216]
NPT737 Cell Line HUVEC Homo sapiens Inhibition = 62.2 % PMID[511216]
NPT737 Cell Line HUVEC Homo sapiens Inhibition = 28.9 % PMID[511216]
NPT2 Others Unspecified Inhibition = 73.4 % PMID[511216]
NPT2 Others Unspecified Inhibition = 21.9 % PMID[511216]
NPT2 Others Unspecified Inhibition = 0.0 % PMID[511216]
NPT2 Others Unspecified IC50 = 58700.0 nM PMID[511216]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC469664 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9806 High Similarity NPC189552
0.9806 High Similarity NPC273467
0.9742 High Similarity NPC186325
0.9742 High Similarity NPC312993
0.9677 High Similarity NPC177650
0.9551 High Similarity NPC55443
0.9551 High Similarity NPC18699
0.9494 High Similarity NPC15374
0.9359 High Similarity NPC121649
0.9359 High Similarity NPC248739
0.9359 High Similarity NPC150908
0.9359 High Similarity NPC205026
0.9359 High Similarity NPC158027
0.9359 High Similarity NPC254351
0.9359 High Similarity NPC186227
0.9359 High Similarity NPC52611
0.9359 High Similarity NPC14606
0.9359 High Similarity NPC265624
0.9359 High Similarity NPC159707
0.9359 High Similarity NPC100049
0.9359 High Similarity NPC215203
0.9308 High Similarity NPC18380
0.9304 High Similarity NPC51760
0.9295 High Similarity NPC303485
0.9295 High Similarity NPC71061
0.9295 High Similarity NPC72425
0.9295 High Similarity NPC194593
0.9295 High Similarity NPC290830
0.9245 High Similarity NPC292863
0.9245 High Similarity NPC470342
0.9245 High Similarity NPC472060
0.9245 High Similarity NPC184326
0.9245 High Similarity NPC472052
0.9236 High Similarity NPC66441
0.9236 High Similarity NPC182555
0.9193 High Similarity NPC290160
0.9187 High Similarity NPC137232
0.9187 High Similarity NPC312273
0.9187 High Similarity NPC472261
0.9187 High Similarity NPC301256
0.9182 High Similarity NPC195167
0.9182 High Similarity NPC324736
0.9172 High Similarity NPC329844
0.9167 High Similarity NPC149526
0.9167 High Similarity NPC111112
0.9167 High Similarity NPC138299
0.9167 High Similarity NPC474417
0.9167 High Similarity NPC222713
0.9167 High Similarity NPC232645
0.9167 High Similarity NPC72958
0.9167 High Similarity NPC67322
0.9161 High Similarity NPC158338
0.9161 High Similarity NPC100985
0.9161 High Similarity NPC97028
0.9161 High Similarity NPC65589
0.9161 High Similarity NPC97029
0.9161 High Similarity NPC288036
0.9157 High Similarity NPC216307
0.9141 High Similarity NPC324522
0.9141 High Similarity NPC105414
0.9141 High Similarity NPC470341
0.9141 High Similarity NPC472058
0.9141 High Similarity NPC234497
0.913 High Similarity NPC473012
0.9119 High Similarity NPC475184
0.9119 High Similarity NPC257166
0.9114 High Similarity NPC300668
0.9114 High Similarity NPC134171
0.9108 High Similarity NPC87708
0.9097 High Similarity NPC256672
0.9097 High Similarity NPC27221
0.9097 High Similarity NPC7025
0.9091 High Similarity NPC477836
0.908 High Similarity NPC251336
0.908 High Similarity NPC30027
0.908 High Similarity NPC477835
0.9074 High Similarity NPC473009
0.9062 High Similarity NPC105584
0.9062 High Similarity NPC51247
0.9062 High Similarity NPC15815
0.9057 High Similarity NPC32867
0.9051 High Similarity NPC210942
0.9051 High Similarity NPC169990
0.9045 High Similarity NPC478148
0.9032 High Similarity NPC7943
0.9032 High Similarity NPC123202
0.9032 High Similarity NPC22005
0.9018 High Similarity NPC473010
0.9006 High Similarity NPC121647
0.9006 High Similarity NPC195136
0.9 High Similarity NPC1796
0.8994 High Similarity NPC226656
0.8994 High Similarity NPC66508
0.8987 High Similarity NPC154683
0.8987 High Similarity NPC40356
0.8987 High Similarity NPC174086
0.8982 High Similarity NPC477991
0.8982 High Similarity NPC477992
0.8981 High Similarity NPC202595
0.897 High Similarity NPC300307
0.897 High Similarity NPC259905
0.897 High Similarity NPC475212
0.8963 High Similarity NPC272502
0.8944 High Similarity NPC295090
0.8944 High Similarity NPC472617
0.8941 High Similarity NPC473631
0.8941 High Similarity NPC293227
0.8941 High Similarity NPC475662
0.8941 High Similarity NPC473717
0.8938 High Similarity NPC146211
0.8938 High Similarity NPC56049
0.8938 High Similarity NPC54830
0.8938 High Similarity NPC69531
0.8935 High Similarity NPC153578
0.8935 High Similarity NPC299149
0.8935 High Similarity NPC277710
0.8935 High Similarity NPC114257
0.8931 High Similarity NPC193200
0.8931 High Similarity NPC324447
0.8931 High Similarity NPC121568
0.8924 High Similarity NPC470569
0.8922 High Similarity NPC213052
0.8917 High Similarity NPC291746
0.8917 High Similarity NPC288840
0.8917 High Similarity NPC477221
0.8917 High Similarity NPC5173
0.8917 High Similarity NPC3642
0.891 High Similarity NPC34802
0.891 High Similarity NPC290194
0.8909 High Similarity NPC253730
0.8909 High Similarity NPC76647
0.8909 High Similarity NPC286230
0.8903 High Similarity NPC224714
0.8902 High Similarity NPC169471
0.8896 High Similarity NPC473011
0.8889 High Similarity NPC42965
0.8889 High Similarity NPC226462
0.8889 High Similarity NPC98023
0.8889 High Similarity NPC470810
0.8882 High Similarity NPC271741
0.8882 High Similarity NPC281137
0.8882 High Similarity NPC208258
0.8882 High Similarity NPC287789
0.8882 High Similarity NPC282390
0.8875 High Similarity NPC79375
0.8875 High Similarity NPC37253
0.8869 High Similarity NPC300657
0.8868 High Similarity NPC43345
0.8868 High Similarity NPC39154
0.8868 High Similarity NPC115601
0.8868 High Similarity NPC273483
0.8868 High Similarity NPC78324
0.8868 High Similarity NPC208011
0.8862 High Similarity NPC4200
0.8861 High Similarity NPC472633
0.8861 High Similarity NPC37348
0.8861 High Similarity NPC147735
0.8861 High Similarity NPC470568
0.8855 High Similarity NPC188079
0.8854 High Similarity NPC106328
0.8854 High Similarity NPC35150
0.8854 High Similarity NPC122894
0.8848 High Similarity NPC320741
0.8848 High Similarity NPC178173
0.8848 High Similarity NPC178851
0.8848 High Similarity NPC171985
0.8846 High Similarity NPC290133
0.8846 High Similarity NPC24136
0.8846 High Similarity NPC187282
0.8839 High Similarity NPC189650
0.8837 High Similarity NPC475352
0.8837 High Similarity NPC229817
0.8837 High Similarity NPC473686
0.8837 High Similarity NPC221140
0.8837 High Similarity NPC475220
0.8837 High Similarity NPC87583
0.8827 High Similarity NPC123544
0.8827 High Similarity NPC90497
0.8827 High Similarity NPC186113
0.8827 High Similarity NPC85121
0.8827 High Similarity NPC228654
0.8824 High Similarity NPC324742
0.882 High Similarity NPC61112
0.882 High Similarity NPC180924
0.882 High Similarity NPC208152
0.882 High Similarity NPC78492
0.882 High Similarity NPC198489
0.8812 High Similarity NPC214632
0.8812 High Similarity NPC135522
0.8805 High Similarity NPC476553
0.8805 High Similarity NPC476551
0.8805 High Similarity NPC476552
0.8805 High Similarity NPC258249
0.8805 High Similarity NPC178484
0.8802 High Similarity NPC298778
0.8797 High Similarity NPC474052
0.8797 High Similarity NPC329933
0.8795 High Similarity NPC474024
0.8788 High Similarity NPC259757
0.8788 High Similarity NPC472051

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC469664 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9554 High Similarity NPD6959 Discontinued
0.8758 High Similarity NPD8443 Clinical (unspecified phase)
0.8718 High Similarity NPD7390 Discontinued
0.8675 High Similarity NPD7852 Clinical (unspecified phase)
0.858 High Similarity NPD7819 Suspended
0.8544 High Similarity NPD7410 Clinical (unspecified phase)
0.8544 High Similarity NPD4378 Clinical (unspecified phase)
0.8509 High Similarity NPD4380 Phase 2
0.8476 Intermediate Similarity NPD7768 Phase 2
0.8466 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.8452 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.8452 Intermediate Similarity NPD6166 Phase 2
0.8452 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.8443 Intermediate Similarity NPD6232 Discontinued
0.8412 Intermediate Similarity NPD5844 Phase 1
0.8402 Intermediate Similarity NPD7473 Discontinued
0.8344 Intermediate Similarity NPD7411 Suspended
0.8304 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.8217 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.8217 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.8204 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.8199 Intermediate Similarity NPD2533 Approved
0.8199 Intermediate Similarity NPD2532 Approved
0.8199 Intermediate Similarity NPD2534 Approved
0.8182 Intermediate Similarity NPD1934 Approved
0.8171 Intermediate Similarity NPD8312 Approved
0.8171 Intermediate Similarity NPD8313 Approved
0.8165 Intermediate Similarity NPD1549 Phase 2
0.8161 Intermediate Similarity NPD6559 Discontinued
0.8153 Intermediate Similarity NPD2796 Approved
0.8103 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.8095 Intermediate Similarity NPD7075 Discontinued
0.8095 Intermediate Similarity NPD3749 Approved
0.8092 Intermediate Similarity NPD7054 Approved
0.8089 Intermediate Similarity NPD1510 Phase 2
0.8072 Intermediate Similarity NPD6801 Discontinued
0.8056 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.805 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.8046 Intermediate Similarity NPD7472 Approved
0.8046 Intermediate Similarity NPD7074 Phase 3
0.8045 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.8036 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8025 Intermediate Similarity NPD1511 Approved
0.8024 Intermediate Similarity NPD2801 Approved
0.8011 Intermediate Similarity NPD7808 Phase 3
0.8 Intermediate Similarity NPD3226 Approved
0.8 Intermediate Similarity NPD6797 Phase 2
0.7975 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7962 Intermediate Similarity NPD1607 Approved
0.7955 Intermediate Similarity NPD7251 Discontinued
0.795 Intermediate Similarity NPD3750 Approved
0.7931 Intermediate Similarity NPD3818 Discontinued
0.7927 Intermediate Similarity NPD1512 Approved
0.7917 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7895 Intermediate Similarity NPD8151 Discontinued
0.7895 Intermediate Similarity NPD5494 Approved
0.7892 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.787 Intermediate Similarity NPD5402 Approved
0.787 Intermediate Similarity NPD3817 Phase 2
0.7834 Intermediate Similarity NPD1240 Approved
0.7812 Intermediate Similarity NPD5408 Approved
0.7812 Intermediate Similarity NPD5405 Approved
0.7812 Intermediate Similarity NPD5404 Approved
0.7812 Intermediate Similarity NPD5406 Approved
0.7778 Intermediate Similarity NPD2800 Approved
0.7778 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7771 Intermediate Similarity NPD5403 Approved
0.7758 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7758 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7738 Intermediate Similarity NPD6599 Discontinued
0.7719 Intermediate Similarity NPD3882 Suspended
0.7709 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7702 Intermediate Similarity NPD6100 Approved
0.7702 Intermediate Similarity NPD6099 Approved
0.7684 Intermediate Similarity NPD7871 Phase 2
0.7684 Intermediate Similarity NPD7870 Phase 2
0.766 Intermediate Similarity NPD6776 Approved
0.766 Intermediate Similarity NPD6782 Approved
0.766 Intermediate Similarity NPD6777 Approved
0.766 Intermediate Similarity NPD6781 Approved
0.766 Intermediate Similarity NPD6778 Approved
0.766 Intermediate Similarity NPD6780 Approved
0.766 Intermediate Similarity NPD6779 Approved
0.7654 Intermediate Similarity NPD2346 Discontinued
0.7651 Intermediate Similarity NPD5401 Approved
0.764 Intermediate Similarity NPD3748 Approved
0.7632 Intermediate Similarity NPD7697 Approved
0.7632 Intermediate Similarity NPD7696 Phase 3
0.7632 Intermediate Similarity NPD7698 Approved
0.7629 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7629 Intermediate Similarity NPD7783 Phase 2
0.7627 Intermediate Similarity NPD7177 Discontinued
0.7622 Intermediate Similarity NPD7003 Approved
0.7611 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7602 Intermediate Similarity NPD8455 Phase 2
0.7602 Intermediate Similarity NPD1465 Phase 2
0.76 Intermediate Similarity NPD3787 Discontinued
0.76 Intermediate Similarity NPD5710 Approved
0.76 Intermediate Similarity NPD5711 Approved
0.7595 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7593 Intermediate Similarity NPD2935 Discontinued
0.7593 Intermediate Similarity NPD1551 Phase 2
0.759 Intermediate Similarity NPD6799 Approved
0.7561 Intermediate Similarity NPD1243 Approved
0.756 Intermediate Similarity NPD920 Approved
0.7541 Intermediate Similarity NPD8150 Discontinued
0.7539 Intermediate Similarity NPD7435 Discontinued
0.7532 Intermediate Similarity NPD4625 Phase 3
0.7528 Intermediate Similarity NPD3751 Discontinued
0.7516 Intermediate Similarity NPD6651 Approved
0.7515 Intermediate Similarity NPD4628 Phase 3
0.75 Intermediate Similarity NPD7229 Phase 3
0.75 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7487 Intermediate Similarity NPD4363 Phase 3
0.7487 Intermediate Similarity NPD4360 Phase 2
0.7474 Intermediate Similarity NPD7701 Phase 2
0.7468 Intermediate Similarity NPD4908 Phase 1
0.7442 Intermediate Similarity NPD37 Approved
0.744 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7439 Intermediate Similarity NPD2344 Approved
0.7425 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7414 Intermediate Similarity NPD4967 Phase 2
0.7414 Intermediate Similarity NPD4966 Approved
0.7414 Intermediate Similarity NPD4965 Approved
0.741 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7403 Intermediate Similarity NPD5953 Discontinued
0.7398 Intermediate Similarity NPD7874 Approved
0.7398 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7396 Intermediate Similarity NPD6273 Approved
0.7396 Intermediate Similarity NPD6823 Phase 2
0.7394 Intermediate Similarity NPD6535 Approved
0.7394 Intermediate Similarity NPD6534 Approved
0.7375 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7368 Intermediate Similarity NPD7699 Phase 2
0.7368 Intermediate Similarity NPD7458 Discontinued
0.7368 Intermediate Similarity NPD7700 Phase 2
0.736 Intermediate Similarity NPD7801 Approved
0.736 Intermediate Similarity NPD3926 Phase 2
0.7345 Intermediate Similarity NPD1247 Approved
0.7345 Intermediate Similarity NPD7199 Phase 2
0.7333 Intermediate Similarity NPD7228 Approved
0.733 Intermediate Similarity NPD6234 Discontinued
0.733 Intermediate Similarity NPD919 Approved
0.7317 Intermediate Similarity NPD2799 Discontinued
0.7305 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7293 Intermediate Similarity NPD7286 Phase 2
0.7267 Intermediate Similarity NPD2313 Discontinued
0.7262 Intermediate Similarity NPD2309 Approved
0.7244 Intermediate Similarity NPD1201 Approved
0.7239 Intermediate Similarity NPD5124 Phase 1
0.7239 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7231 Intermediate Similarity NPD8320 Phase 1
0.7231 Intermediate Similarity NPD8319 Approved
0.7212 Intermediate Similarity NPD7033 Discontinued
0.7202 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7181 Intermediate Similarity NPD4287 Approved
0.7173 Intermediate Similarity NPD4361 Phase 2
0.7173 Intermediate Similarity NPD4362 Clinical (unspecified phase)
0.717 Intermediate Similarity NPD1470 Approved
0.7167 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7166 Intermediate Similarity NPD8434 Phase 2
0.716 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7158 Intermediate Similarity NPD6212 Phase 3
0.7158 Intermediate Similarity NPD6214 Clinical (unspecified phase)
0.7158 Intermediate Similarity NPD6213 Phase 3
0.7151 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.715 Intermediate Similarity NPD8285 Discontinued
0.7143 Intermediate Similarity NPD7893 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD5698 Clinical (unspecified phase)
0.7122 Intermediate Similarity NPD8155 Clinical (unspecified phase)
0.7112 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7102 Intermediate Similarity NPD5760 Phase 2
0.7102 Intermediate Similarity NPD5761 Phase 2
0.7081 Intermediate Similarity NPD7654 Discontinued
0.7073 Intermediate Similarity NPD1613 Approved
0.7073 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7073 Intermediate Similarity NPD943 Approved
0.7071 Intermediate Similarity NPD7584 Approved
0.7062 Intermediate Similarity NPD4288 Approved
0.7056 Intermediate Similarity NPD8127 Discontinued
0.7055 Intermediate Similarity NPD3268 Approved
0.7055 Intermediate Similarity NPD1699 Clinical (unspecified phase)
0.7051 Intermediate Similarity NPD1651 Approved
0.7045 Intermediate Similarity NPD6844 Discontinued
0.7044 Intermediate Similarity NPD4749 Approved
0.7037 Intermediate Similarity NPD6832 Phase 2
0.7025 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7025 Intermediate Similarity NPD1610 Phase 2
0.7019 Intermediate Similarity NPD2798 Approved
0.7006 Intermediate Similarity NPD4308 Phase 3
0.7 Intermediate Similarity NPD1283 Approved
0.6989 Remote Similarity NPD7615 Clinical (unspecified phase)
0.6989 Remote Similarity NPD7240 Approved
0.6987 Remote Similarity NPD1548 Phase 1
0.697 Remote Similarity NPD2979 Phase 3
0.6964 Remote Similarity NPD2438 Suspended
0.6957 Remote Similarity NPD1203 Approved
0.6957 Remote Similarity NPD2797 Approved
0.6951 Remote Similarity NPD3764 Approved
0.694 Remote Similarity NPD7784 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data